Outcomes of Childhood Asthma and Wheezy Bronchitis. A 50-Year Cohort Study.
BACKGROUND
Cohort studies suggest that airflow obstruction is established early in life, manifests as childhood asthma and wheezy bronchitis, and continues into early adulthood. Although an association between childhood asthma and chronic obstructive pulmonary disease (COPD) in later life has been demonstrated, it is unclear if childhood wheezy bronchitis is associated with COPD.


OBJECTIVE
To investigate whether childhood wheezy bronchitis increases the risk of COPD in the seventh decade.


METHODS
A cohort of children recruited in 1964 at age 10 to 15 years, which was followed up in 1989, 1995, and 2001, was followed up again in 2014 when at age 60 to 65 years. Discrete time-to-event and linear mixed effects models were used.


RESULTS
FEV1 and FVC were measured. COPD was defined as post-bronchodilator FEV1/FVC <0.7. Childhood wheezing phenotype was related to 1989, 1995, 2001, and 2014 spirometry data. Three hundred thirty subjects, mean age 61 years, were followed up: 38 with childhood asthma; 53 with childhood wheezy bronchitis; and 239 control subjects (of whom 57 developed adulthood-onset wheeze between ages 16 and 46 yr). In adjusted multivariate analyses, childhood asthma was associated with an increased risk of COPD (odds ratio, 6.37; 95% confidence interval, 3.73-10.94), as was childhood wheezy bronchitis (odd ratio 1.81; 95% confidence interval, 1.12-2.91). The COPD risk increased with childhood asthma, and wheezy bronchitis was associated with reduced FEV1 that was evident by the fifth decade and not an accelerated rate of FEV1 decline. In contrast, adulthood-onset wheeze was associated with accelerated FEV1 decline.


CONCLUSIONS
Childhood wheezy bronchitis and asthma are associated with an increased risk of COPD and reduced ventilatory function.
1 Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom; and.
Nara
N
Tagiyeva
1 Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom; and.
Graham
G
Devereux
1 Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom; and.
Shona
S
Fielding
1 Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom; and.
Stephen
S
Turner
2 Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom.
Graham
G
Douglas
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D001249:Asthma / Q000150:complications*; D001991:Bronchitis / Q000150:complications*; D002648:Child; D015331:Cohort Studies; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology*; D012135:Respiratory Sounds / Q000209:etiology; D012307:Risk Factors; D014797:Vital Capacity; D055815:Young Adult
asthma; childhood wheezing phenotypes; chronic obstructive pulmonary disease; pulmonary function decline